Titan Medical Partners With EVC Group

TORONTO, ON--(Marketwired - March 07, 2016) - Titan Medical, Inc. (TSX: TMD) (OTCQX: TITXF), has retained the award winning investor relations firm, EVC Group, to create and execute an investor relations program addressing current as well as potential investors in Canada and the United States. An EVC Group account team based in New York and Los Angeles is managing the program.

"EVC Group has a substantial track record for creating investor relations programs that help management teams enhance valuation," said John Hargrove, Chairman and Chief Executive Officer of Titan Medical Inc. "The firm has particularly strong experience with emerging medical device as well as surgical robotics companies. In addition, their account team has nearly 100 years of combined healthcare industry investor relations experience as well as hundreds of healthcare industry investor relationships that will be put to work for our company. 2016 has the potential to be a very positive year for Titan Medical. We look forward to working with the EVC Group team to maximize awareness of our potential, our achievements, and our focus on building value for our shareholders."

About Titan Medical Inc.

Titan Medical Inc. is a Canadian public company focused on the design and development of a robotic surgical system for application in minimally invasive surgery ("MIS"). The Company's SPORT™ Surgical System, currently under development, includes a surgeon-controlled robotic platform that incorporates a 3D high-definition vision system and multi-articulating instruments for performing MIS procedures through a single incision. The surgical system also includes a surgeon workstation that provides a surgeon with an advanced ergonomic interface to the robotic platform for controlling the instruments and provides a 3D high-definition endoscopic view of inside a patient's body. The SPORT™ Surgical System is designed to enable surgeons to perform a broad set of surgical procedures for general abdominal, gynecologic, and urologic indications. For more information, visit the Company's website at www.titanmedicalinc.com.

Forward-Looking Statements

This news release contains "forward-looking statements" which reflect the current expectations of management of the Company's future growth, results of operations, performance and business prospects and opportunities. Wherever possible, words such as "may", "would", "could", "will", "anticipate", "believe", "plan", "expect", "intend", "estimate", "potential for" and similar expressions have been used to identify these forward-looking statements. These statements reflect management's current beliefs with respect to future events and are based on information currently available to management. Forward-looking statements involve significant risks, uncertainties and assumptions. Many factors could cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements, including, without limitation, those listed in the "Risk Factors " section of the Company's Annual Information Form dated March 31, 2015 (which may be viewed at www.sedar.com). Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward looking statements prove incorrect, actual results, performance, or achievements may vary materially from those expressed or implied by the forward-looking statements contained in this news release. These factors should be considered carefully, and prospective investors should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in the news release are based upon what management currently believes to be reasonable assumptions, the Company cannot assure prospective investors that actual results, performance or achievements will be consistent with these forward-looking statements.